BTAI Live signals | Maximize Profits with Getagraph.com

BUY 112403 min ago

@ $3.11

Issued: 14 Feb 2024 @ 13:43

Return: -17.68%

Previous signal: Feb 14 - 11:27

Previous signal: Sell

Return: 3.15 %

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 16:00):

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology...

Stats
Today's Volume	203 380
Average Volume	1.55M
Market Cap	94.81M
EPS	$0 ( 2024-03-12 )
Next earnings date	( $-0.680 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.420
ATR14	$0.00500 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	O'neill Vincent	Sell	2 250	Restricted Stock Units
2024-03-15	O'neill Vincent	Buy	2 250	Common Stock
2024-04-04	O'neill Vincent	Sell	165	Common Stock
2024-03-14	O'neill Vincent	Sell	521	Restricted Stock Units
2024-03-14	O'neill Vincent	Buy	521	Common Stock

INSIDER POWER
-8.70
Last 87 transactions
Buy: 187 774 \| Sell: 228 648

Volume Correlation

Long: -0.02 (neutral)

Short: 0.27 (neutral)

Signal:(54.791) Neutral

BioXcel Therapeutics Inc Correlation

10 Most Positive Correlations
AGNC	0.927
NWL	0.905
BOCH	0.904
PRAX	0.896
YQ	0.896
SLVO	0.894
GRFS	0.893
SHYF	0.891
CASS	0.888
CLPS	0.888

10 Most Negative Correlations
CRSA	-0.937
LONE	-0.906
PPBT	-0.903
SNCR	-0.902
TSLA	-0.897
MVBF	-0.882
TLMD	-0.88
EPZM	-0.878
RMRM	-0.876
MTEK	-0.876

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BioXcel Therapeutics Inc Correlation - Currency/Commodity

0.17
( neutral )

0.06
( neutral )

0.00
( neutral )

0.13
( neutral )

-0.18
( neutral )

BioXcel Therapeutics Inc Financials

Annual	2023
Revenue:	$1.38M
Gross Profit:	$-198 000 (-14.35 %)
EPS:	$-6.15

FY	2023
Revenue:	$1.38M
Gross Profit:	$-198 000 (-14.35 %)
EPS:	$-6.15

FY	2022
Revenue:	$375 000
Gross Profit:	$355 000 (94.67 %)
EPS:	$-6.13

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

BioXcel Therapeutics Inc

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The company also continues to conduct clinical trials evaluating BXCL501 for the treatment of agitation in Alzheimer's disease patients, and for adjunctive treatment of patients with major depressive disorder, as well as in the community for agitation associated with bipolar disorders and schizophrenia. In addition, it is developing BXCL502 as a potential therapy for chronic agitation in dementia; and BXCL701, an investigational, orally administered, systemic innate immunity activator for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut.